GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ASEP Medical Holdings Inc (OTCPK:SEPSF) » Definitions » DeferredTaxAndRevenue

ASEP Medical Holdings (ASEP Medical Holdings) DeferredTaxAndRevenue : $0.17 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is ASEP Medical Holdings DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

ASEP Medical Holdings's current deferred tax and revenue for the quarter that ended in Mar. 2024 was $0.17 Mil.

ASEP Medical Holdings DeferredTaxAndRevenue Historical Data

The historical data trend for ASEP Medical Holdings's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASEP Medical Holdings DeferredTaxAndRevenue Chart

ASEP Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23
DeferredTaxAndRevenue
- - 0.22

ASEP Medical Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.22 0.17

ASEP Medical Holdings DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of ASEP Medical Holdings's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


ASEP Medical Holdings (ASEP Medical Holdings) Business Description

Traded in Other Exchanges
Address
730 View Street, Suite 420, Victoria, BC, CAN, V8W 3Y7
ASEP Medical Holdings Inc is a biotechnology firm pursuing the commercialization of broad-spectrum peptide technology. The Company is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine and is engaged in the business of acquiring research and development assets, technology, or businesses in life sciences and medical diagnostics.

ASEP Medical Holdings (ASEP Medical Holdings) Headlines

From GuruFocus